Unexplained Cardiac Uptake on ^99mTc-MDP Bone Scan in a Patient with Prostate Cancer

Area of Science:

• Nuclear medicine
• Oncology
• Radiology

Background:

• Bone scintigraphy using technetium-99m methylene diphosphonate (^99mTc-MDP) is a standard imaging modality for evaluating prostate cancer metastasis.
• Cardiac uptake on ^99mTc-MDP scans can indicate cardiac amyloidosis, a serious condition requiring specific diagnosis and management.
• Metastatic prostate cancer can sometimes be associated with increased cardiac uptake on bone scans, though the underlying mechanisms are not fully understood.

Observation:

• An 83-year-old male patient with metastatic prostate cancer demonstrated unusual diffuse cardiac uptake (Perugini 3) on a baseline ^99mTc-MDP bone scan.
• Follow-up bone scan approximately 4.4 months later showed near-complete resolution of the cardiac uptake (Perugini 1).
• Laboratory tests and imaging ruled out cardiac amyloidosis, and no other specific causes were identified.

Findings:

• The cardiac uptake was ultimately deemed non-specific, given its resolution over a short period.
• While non-specific cardiac uptake is known in elderly prostate cancer patients, potentially due to atherosclerosis, the rapid resolution in this case makes this explanation less likely.
• The case highlights the importance of considering non-specific uptake as a differential diagnosis for cardiac findings on bone scintigraphy.

Implications:

• Clinicians must differentiate between pathological cardiac uptake (e.g., amyloidosis) and non-specific findings on bone scans.
• Non-specific cardiac uptake on ^99mTc-MDP bone scans may not necessitate immediate medical intervention but rather careful follow-up.
• This case broadens the understanding of potential causes of cardiac uptake in nuclear medicine, emphasizing the need for comprehensive patient evaluation and serial imaging.